Latest news with #Medicare-certified
Yahoo
2 days ago
- Business
- Yahoo
ZoomCare Opens New Clinic in Happy Valley
The company will host an Open House for the community on Jun. 13 PORTLAND, Ore., June 10, 2025 /PRNewswire/ -- ZoomCare, a network of neighborhood clinics serving a wide variety of healthcare needs, today announced the opening of a new clinic to serve the community of Happy Valley. The new clinic is located at 17155 SE Sunnyside Road, Suite #160 in the Happy Valley Crossroads Shopping Center. The clinic will be open seven days a week. Staffed with board-certified providers who cater to a broad range of illnesses and injuries, the Happy Valley clinic will also include preventive care services. The location features five exam rooms and offers on-site labs and prescriptions, allowing patients to leave with medications in hand. Since 2006, ZoomCare has been known for its patient experience, which is focused on compassion, quality, and efficiency. "ZoomCare believes you shouldn't have to travel far to receive excellent care," said Jeff Fee, Chief Executive Officer of ZoomCare. "We are thrilled to join the Happy Valley community. Opening this new location aligns perfectly with our mission to make healthcare easy and accessible for everyone." The company will celebrate the new clinic opening with an Open House event on Friday, Jun. 13, from 11 a.m. - 2 p.m. The Open House is open to the public and will offer free specialty coffee drinks and Italian sodas, fun giveaways, and a chance to meet the provider team and see the new clinic space. "This Open House is an excellent opportunity for our providers and clinic staff to get to know the people of Happy Valley," said Jennifer Alemany, Director of Clinical Operations in Portland. "We hope folks will come by, meet our team, and learn more about how ZoomCare can help with their healthcare needs now and in the future!" ZoomCare accepts Medicare and Medicare Advantage at all of its 47 locations in Oregon and Washington. Using Medicare-certified software platform Athenahealth, ZoomCare can access and share electronic health records with other providers and health systems. This certified software platform also lets ZoomCare establish partnerships with large health systems and insurance plans to increase patient access to primary, urgent, emergency, and specialty care. About ZoomCareZoomCare's vision is to make healthcare easy. Founded in 2006 in Portland, Oregon, ZoomCare operates more than 47 urgent, primary, emergency care, and specialty locations throughout Oregon and Washington. With conveniently located neighborhood clinics, plus evening and weekend hours, ZoomCare is committed to providing better access to healthcare and delivering evidence-based care with kindness at every visit. For more information, visit Follow ZoomCare on Facebook, Instagram, LinkedIn, and X. Media ContactAmanda Gibbs Director of Communications agibbs@ View original content to download multimedia: SOURCE ZoomCare
Yahoo
20-05-2025
- Health
- Yahoo
ECG Disposables Market Analysis (2025-2030) by Product, Patient Demographics, Application, End-use, and Region with Growth Forecasts
Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "ECG Disposable Market Size, Share & Trends Analysis Report by Product (Wet Gel Electrodes, Dry Electrodes), Patient Demographics (Adult, Pediatric, Neonatal), Application, End-use, Region, with Growth Forecasts, 2025-2030" has been added to ECG Disposable Market was valued at USD 500.58 Million in 2024, and is projected to reach USD 648.15 Million by 2030, rising at a CAGR of 4.40%. The increasing global burden of CVDs, such as heart attacks, arrhythmias, and heart failure, necessitates frequent and accurate cardiac monitoring. Disposable ECG equipment plays a crucial role in this monitoring, driving its demand. For instance, the WHO estimates that CVDs are the leading cause of death worldwide, accounting for a significant percentage of global mortality each year. This large patient pool requiring ECG monitoring fuels the need for disposable electrodes and disposable lead high and increasing global incidence of heart diseases, collectively known as cardiovascular diseases (CVDs), is a primary driver for the disposable Electrocardiogram (ECG) equipment market. The table highlight the rising prevalence of heart disease in the globe in growing geriatric population is a significant driver of the ECG disposable market, as older adults are more prone to cardiovascular diseases and related health complications. As individuals age, the likelihood of developing heart conditions such as arrhythmias, hypertension, and heart failure increases, leading to a higher demand for regular monitoring of heart health. Disposable, portable, cost-effective, and easy-to-use ECGs offer an efficient solution for continuous heart health monitoring in elderly patients. The rise in chronic diseases among the aging population and the convenience and affordability of disposable ECG devices are accelerating their adoption in healthcare settings, home care environments, and wellness monitoring, further driving market the growing trend of delivering healthcare services outside traditional hospital settings, such as in homes and ambulatory care centers, is increasing the demand for convenient and user-friendly disposable ECG equipment to monitor patients in these environments. For instance, in the U.S., there are currently 11,555 ASCs, including 6,382 Medicare-certified ASCs and 5,173 non-Medicare-certified ASCs. Furthermore, healthcare facilities are increasingly focused on preventing hospital-acquired infections (HAIs). Disposable ECG equipment eliminates the risk of cross-contamination associated with reusable electrodes and lead wires, making it a preferred choice for maintaining hygiene and patient safety. Regulatory bodies and hospital protocols emphasizing infection control measures further propel the adoption of disposable ECG ECG Disposable Market Report: SegmentationThis report forecasts revenue & volume growth of the ECG disposable market and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, the analyst has segmented the global ECG disposable market report based on product, patient demographics, application, end-use, and region:Product Type Outlook (Revenue, USD Million, 2018-2030) Wet Gel Electrodes Dry Electrodes Hydrocolloid Electrodes Foam Electrodes Others Patient Demographics Outlook (Revenue, USD Million, 2018-2030) Adult Pediatric Neonatal Application Outlook (Revenue, USD Million, 2018-2030) Diagnostic Monitoring End-use Outlook (Revenue, USD Million, 2018-2030) Hospitals Ambulatory Care Centers Others Regional Outlook (Revenue, USD Million, 2018-2030) North America Europe Asia-Pacific Latin America Middle East & Africa Why Should You Buy This Report? Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments. Competitive Landscape: Explore the market presence of key players. Future Trends: Discover the pivotal trends and drivers shaping the future of the market. Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions. This report addresses: Market intelligence to enable effective decision-making Market estimates and forecasts from 2018 to 2030 Growth opportunities and trend analyses Segment and regional revenue forecasts for market assessment Competition strategy and market share analysis Product innovation listings for you to stay ahead of the curve Key Attributes Report Attribute Details No. of Pages 100 Forecast Period 2024-2030 Estimated Market Value (USD) in 2024 $500.58 Million Forecasted Market Value (USD) by 2030 $648.15 Million Compound Annual Growth Rate 4.4% Regions Covered Global The companies profiled in this ECG Disposable market report include: 3M A.M.I. ITALIA AthenaDiax Baisheng Medical Equipment BioTekna BPL Medical Technologies Cardiolex ConMed Harvard Apparatus INTCO Medical Intelesens AB Medica Group LUMED Med-link Electronics Tech Co. Ambu A/S Nihon Kohden Europe Tenocom Medical Technology Co. Ltd. For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. CONTACT: CONTACT: Laura Wood,Senior Press Manager press@ For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20-03-2025
- Health
- Yahoo
New Hampshire House tables legalized assisted suicide bill
The New Hampshire House of Representatives meets for a voting day in the State House on Thursday, March 20, 2025. Representatives voted to table a proposal legalizing assisted suicide. (Photo by William Skipworth/New Hampshire Bulletin) By a single vote, the New Hampshire House of Representatives decided to table a proposal to legalize assisted suicide. House Bill 254, sponsored by Windham Republican Rep. Bob Lynn, seeks to legalize medical aid in dying in New Hampshire. If enacted, it would allow adults to end their life through doctor-prescribed drugs. In order to receive the fatal drugs under this bill, two different doctors would have to determine those adults to be likely to die within six months or they would have to be in Medicare-certified hospice care with a terminal condition. The patient receiving aid-in-dying drugs would also need to have the mental capacity to 'understand and appreciate health care options available' and give informed consent. The drugs must be self-administered. The medical provider must also determine the patient is not being coerced into the assisted suicide. IF YOU OR SOMEONE YOU KNOW is in a crisis, call, text or chat the Suicide and Crisis Lifeline at 988. To reach the New Hampshire Rapid Response Access Point, call or text 833-710-6477. If you need help with grief and loss, the American Foundation for Suicide Prevention offers advice and resources. You can also call the National SAMHSA Helpline, 1-800-662-HELP, with services in English and Spanish, toll free 24/7. By tabling this bill, the House decided not to advance it to the Senate, but didn't kill it entirely. Lawmakers can still bring it back up for a vote should they choose. The bipartisan vote to table it was 183-182. 'I do enjoy a debate of nine speakers such as we have lined up here as much as the next guy,' House Majority Leader Jason Osborne said, advocating for the House to skip debate and simply table it. 'But I also know that we don't need to have the same debate every year.' The debate over assisted suicide is not a new one in the New Hampshire State House. The practice was almost legalized last year when 2024's House Bill 1283, a very similar piece of legislation, was approved by the House, but failed in the Senate. In hearings leading up to Thursday's vote, proponents of the bill argued it provides a way for people with terminal illnesses and conditions to avoid some of the suffering they may face in their final days of life. Opponents of the bill argued it would lead to a so-called slippery slope where doctors give up on treating people with disabilities and severe conditions in favor of encouraging them to choose death. Opponents were also concerned it would be abused by people with depression and suicidal ideation. Assisted suicide is already legal in 10 U.S. states — including Vermont and Maine — and Washington, D.C. It's also legal in countries like Canada, Switzerland, Australia, New Zealand, and Belgium.
Yahoo
13-02-2025
- Health
- Yahoo
New Hampshire is debating legalized assisted suicide. Here's how it's worked out elsewhere.
Signs in the State House express support for the "New Hampshire End of Life Freedom Act." (Photo by William Skipworth/New Hampshire Bulletin) Lindsey Warren, of Coventry, Vermont, has helped many people end their lives using medical aid-in-dying drugs. 'I've seen so many people happy and relieved that they have choice and dignity in the end of their life,' she said. 'Everyone that I've worked with has been overjoyed that they made it to the day. They're able to choose. They're able to say their goodbyes to their family. And they've been fighting the good fight, but they are really ready to rest and not be in pain and suffering anymore.' Warren is an end-of-life doula. Her job is to help people navigate different aspects of end-of-life care including medical aid-in-dying, also known as assisted suicide (though she, and other proponents, prefer the term medical aid-in-dying), which is legal in Vermont. This includes guiding them through the eligibility and approval process required of patients for them to receive medical aid-in-dying drugs as well as helping with doctors appointments. She said having the practice legalized is 'absolutely a positive' for Vermont. 'Every step along the way, it's always their choice,' she said. 'And they may decide to, in the end, not ingest (the aid-in-dying drugs) but at least they knew they had that choice and they explored that.' Warren said she hasn't seen a lot of the common criticisms of assisted suicide – people with disabilities being pressured into it, people with depression and suicidal ideation abusing it – come to fruition, but she has seen long wait times, especially as people from other states come to receive the drugs. She hopes other states, like New Hampshire, will legalize the practice to take pressure off Vermont's system. And many in New Hampshire share that hope. New Hampshire could soon become the 11th U.S. state to legalize assisted suicide as lawmakers debate the so-called New Hampshire End of Life Freedom Act. IF YOU OR SOMEONE YOU KNOW is in a crisis, call, text or chat the Suicide and Crisis Lifeline at 988. To reach the New Hampshire Rapid Response Access Point, call or text 833-710-6477. If you need help with grief and loss, the American Foundation for Suicide Prevention offers advice and resources. You can also call the National SAMHSA Helpline, 1-800-662-HELP, with services in English and Spanish, toll free 24/7. If passed, House Bill 254 would allow adults who have been determined by two doctors to have an estimated six months left to live or are in Medicare-certified hospice care to end their life through aid-in-dying drugs in New Hampshire. The patient receiving the drug must have the mental capacity to understand their options and decision, must be able to self-administer the medication, and must give informed consent. The provider is also required to confirm the patient isn't being coerced. At a hearing in the State House last month, Rep. Bob Lynn, the Windham Republican who introduced the bill, said it was about 'giving people at the end of their life the freedom to end their life in a dignified way rather than endure continuous suffering.' At the hearing, advocates said the bill allows people already near death to end their life on their own terms and avoid the suffering they may face in the lead-up to their death. Opponents argued the bill has a number of flaws, including that it would encourage medical providers to give up on treating people facing severe disabilities or other conditions in favor of ending their lives or that it would be abused by people suffering from depression and suicidal ideation. Gov. Kelly Ayotte said last week she hadn't yet looked at the bill and declined to provide her stance. 'It is a very important issue, and I know that it's an issue that people on both sides of it have deep concerns about,' she added. If the bill becomes law, New Hampshire would be far from the first state or country to legalize assisted suicide. Between criticisms of the practice being used to euthanize the poor and disabled in Canada and disapproval from the American Medical Association to popularity across the U.S. and a surge of travel to Switzerland, the practice has seen a mixed reception. Assisted suicide is legal on both New Hampshire's west and east borders, in Vermont and Maine. In 2013, Vermont became the fourth U.S. state to legalize assisted suicide. Act 39, also known as the Vermont Patient Choice and Control at End of Life law, allows terminally ill patients with a prognosis of six months left to live to receive medical aid in dying in Vermont. The medical aid in dying drugs have to be self-administered, and the patient must be deemed capable of making their own health care decisions and giving informed consent. Vermont's law is very similar to New Hampshire's proposal. From 2013, when the bill was passed, through June 2023, the most recent data available, 203 people ended their lives through this act, according to the Vermont Department of Health. Eighty-five of those occurred from July 1, 2021, to June 30, 2023. The most common diagnosis cited by patients ending their life was cancer, with 153 cases, or 75%; 26, or 13%, were due to neurodegenerative conditions while 6, or 3%, were end-stage lung diseases like COPD or emphysema. In 2019, Maine joined Vermont in legalizing assisted suicide through the Maine Death with Dignity Act. The law allows for assisted suicide in patients with an incurable terminal illness that is expected to kill them within six months. Maine's law also requires the patient to be able to self-administer the drug and be of sound mind. In Maine, the patient must be a legal resident of the state, which is not the case in Vermont (though it was prior to May 2023) and New Hampshire's proposal. In 2023, 80 patients began the process in Maine to receive aid-in-dying drugs, according to the Maine Department of Health and Human Services, though four died before completing the process and nine were still alive at the time of the department's report. From 2019 to 2022, 117 people have been prescribed and taken this life-ending drug in Maine. As in Vermont, cancer is the most common diagnosis for these patients in 2023, representing 42 of them, or 53%. Six of them were diagnosed with ALS and five had heart disease or a cardiac condition. Including Vermont and Maine, there are 10 U.S. states plus Washington, D.C., where the practice is legal. The others are Oregon, Washington, Montana, California, Colorado, Hawaii, New Jersey, and New Mexico. In Montana, assisted suicide is legal only through a common law legal precedent established by the Supreme Court case Baxter v. Montana in 2009. All other states legalized it through legislation. In total, 22% of Americans live somewhere with legal assisted suicide. And it's popular across the country, with 71% of respondents in an August Gallup poll saying they believe doctors should be 'allowed by law to end the patient's life by some painless means if the patient and his or her family request it.' However, some physicians in the U.S. aren't as supportive. The American Medical Association says that the practice violates its code of ethics. 'Physician-assisted suicide is fundamentally incompatible with the physician's role as healer, would be difficult or impossible to control and would pose serious societal risks,' the association wrote. Quebec became the first Canadian province to legalize assisted suicide in 2014. Since then, however, the Canadian Supreme Court has ruled it legal for all Canadians. After multiple expansions, Canadian law includes some of the world's most permissive policies on assisted suicide. Since 2021, a patient does not have to be terminally ill to receive the drugs in Canada, but rather may be experiencing a long and complicated condition – including disability alone – that impacts their quality of life. The law there also allows a provider to directly administer the drugs rather than require the patient self-administer. (When a provider administers the drug, it's called euthanasia.) Some opponents have called these expansions part of a so-called slippery slope. The practice has exploded there. Assisted dying now represents roughly 1 in 20 Canadian deaths, according to an annual report released in December by Health Canada with data from 2023, the most recent available. That's 15,300 deaths, or 4.7% of deaths in the country. Most – roughly 96% – had a terminal illness, but a small minority – around 4% – fit into the category of illness with a natural death not 'reasonably foreseeable.' The median age was 77.7. In recent years, Canada's assisted-suicide policies have garnered criticism for disproportionately being used by the poor and disabled. An Associated Press investigation in October found that the highest numbers of assisted deaths for patients not facing terminal illness came from the poorest areas. The AP also found medical providers expressing deep discomfort carrying out some of their assisted-dying requests, some of which were avoidable deaths. Additionally, the investigation told the story of someone who was euthanized even after their doctor concluded their suffering was mostly because they were homeless, in debt, and unwilling to accept long-term care, as well as someone who specifically told their doctor that the government's small amount of disability support for their ankle and back injury left them no choice but to request medical aid-in-dying, among others. However, the AP concluded poverty doesn't seem disproportionately prominent among recipients with terminal diseases, which would be the only recipients allowed in New Hampshire under its proposal. A Spectator thought piece entitled 'Why is Canada euthanizing the poor?' and an article from The Guardian, 'Are Canadians being driven to assisted suicide by poverty or healthcare crisis?', both from 2022, delved into the same concerns. In 2020, Roger Foley, a man with a neurodegenerative disease, testified to the Canadian Parliament that medical providers attempted to coerce him into assisted suicide by threatening high rates for the care he needed or to forcibly discharge him. 'Assisted dying is easier to access than safe and appropriate disability supports to live,' Foley said. Assisted suicide is legal in Australia, Austria, the Netherlands, New Zealand, Spain, and Switzerland, among others. In 1941, Switzerland was the first country in the world to legalize assisted suicide, though euthanasia – having a provider administer the aid-in-dying drugs – is illegal there. While critics deem it 'suicide tourism,' the country permits foreigners to travel there for assisted suicide. This has been praised by participants' friends and families who say it gives them a good option to end their lives on their own terms. In New Hampshire, the friend of one such person, Hope Damon, who is also a member of the state House of Representatives, told lawmakers the story last month of her friend Michael, who traveled to Switzerland to die. 'We sadly and joyfully celebrated the loss and that he was able to choose to end his life on the terms that were right for him and save his family from watching a heart-wrenchingly sad decline,' she said, urging lawmakers to legalize assisted suicide. The Netherlands and Belgium have gone so far as to legalize assisted dying for children. A study from a group of Belgian researchers found that almost all participants they examined wanted their family member with cancer's medical aid-in-dying request to be granted, and some of them even took an active supportive role in the process. A study from researchers in the Netherlands, while older – from 2003 – also examined the impact of the practice on family members, showing that friends and family of cancer patients who died through euthanasia displayed less traumatic grief symptoms, felt less grief in the moment, and had less post-traumatic stress reactions than friends and family of patients who died of natural causes.
Yahoo
30-01-2025
- Business
- Yahoo
Enhabit Home Health & Hospice Earns 2025 Great Place To Work Certification™
DALLAS, January 30, 2025--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, announced today that it is proud to be Certified™ by Great Place To Work®. This prestigious award is based entirely on the experiences of current employees working at Enhabit. This year, 83% of employees said it's a great place to work, which is 26 points higher than the average U.S. company. Great Place To Work® is the global authority on workplace culture, employee experience and leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation. "Receiving the Great Place To Work Certification™ is a testament to the relentless hard work and dedication of our Enhabit team members. Their unwavering commitment and daily contributions have been instrumental in building a positive work environment and fostering a strong company culture. This recognition truly belongs to them, and I couldn't be more grateful for their efforts in making Enhabit a great place to work," said Enhabit President and Chief Executive Officer Barb Jacobsmeyer. "Winning this certificate is a testament to the vibrant and supportive culture we've built together at Enhabit. Our team consistently creates an environment where everyone can excel," said Enhabit Chief Human Resources Officer Tanya Marion. Enhabit is one of the largest Medicare-certified home health and hospice providers in the nation, with over 10,000 employees across its vast footprint. Enhabit offers flexible schedules, professional development opportunities, a competitive compensation and benefits package and access to advanced technology to assist employees in providing industry-leading care to patients and their loved ones. To learn more about Enhabit and its care offerings, visit To learn more about joining the Enhabit team, visit About Enhabit Home Health & Hospice Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what's possible for patient care in the home. Enhabit's team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 256 home health locations and 112 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit About Great Place to Work Certification™ Great Place To Work® Certification™ is the most definitive "employer-of-choice" recognition that companies aspire to achieve. It is the only recognition based entirely on what employees report about their workplace experience – specifically, how consistently they experience a high-trust workplace. Great Place to Work Certification is recognized worldwide by employees and employers alike and is the global benchmark for identifying and recognizing outstanding employee experience. Every year, more than 10,000 companies across 60 countries apply to get Great Place To Work-Certified. View source version on Contacts Media contact Erin Volbedamedia@ 972-338-5141 Investor contact Jobie Williamsinvestorrelations@ 469-860-6061 Sign in to access your portfolio
